Research article
Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds
-
* Corresponding author: Sorel Muresan sorel.muresan@astrazeneca.com
1 ChrisDS Consulting, S-42166, Göteborg, Sweden
2 EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK
3 DECS Global Compound Sciences, Computational Chemistry, AstraZeneca R&D Mölndal, S-43183 Mölndal, Sweden
Journal of Cheminformatics 2009, 1:10 doi:10.1186/1758-2946-1-10
Published: 6 July 2009Additional files
Additional file 1:
The comparison matrix. Table Three – The comparison matrix. Each heading corresponds to one of the data sets described in Methods. The 23 × 23 matrix can be reviewed from left to right across the columns and down the rows in database order.
Format: DOC Size: 85KB Download file
This file can be viewed with: Microsoft Word Viewer
